Page last updated: 2024-10-25

cimetidine and Nasopharyngeal Neoplasms

cimetidine has been researched along with Nasopharyngeal Neoplasms in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eshchar, J1
Neuman, MG1
Pavlotzky, M1
Saibil, FG1
Zeng, P1
Xiao, J1
Lei, Y1

Trials

1 trial available for cimetidine and Nasopharyngeal Neoplasms

ArticleYear
[Cell-mediated immune function in NPC patients treated with cimetidine].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:3

    Topics: Adjuvants, Immunologic; Adult; Carcinoma, Squamous Cell; CD4-CD8 Ratio; Cimetidine; Female; Humans;

1995

Other Studies

1 other study available for cimetidine and Nasopharyngeal Neoplasms

ArticleYear
Zollinger-Ellison syndrome, prolonged cimetidine administration and nasopharyngeal carcinoma:--a coincidence?
    International journal of tissue reactions, 1983, Volume: 5, Issue:4

    Topics: Cimetidine; Herpesvirus 4, Human; Humans; Lymphocytes; Male; Middle Aged; Nasopharyngeal Neoplasms;

1983